The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay

• Hansook Kim Chong,

  Affiliation Department of Research and Development, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Tao Wang,

  Affiliation Department of Bioinformatics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Hsiao-Mei Lu,

  Affiliation Department of Bioinformatics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Sara Seidler,

  Affiliation Department of Research and Development, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Hong Lu,

  Affiliation Department of Bioinformatics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Steven Keiles,

  Affiliation Department of Clinical Genetics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Elizabeth C. Chao,

  Affiliation Department of Clinical Genetics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• A. J. Stuenkel,

  Affiliation Department of Clinical Genetics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Xiang Li,

  Affiliation Department of Bioinformatics, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯
• Aaron M. Elliott

  * E-mail: aelliott@ambrygen.com

  Affiliation Department of Research and Development, Ambry Genetics, Aliso Viejo, California, United States of America

  ⨯